首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of biomolecular screening

缩写:J BIOMOL SCREEN

ISSN:1087-0571

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引728
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chad W Johnson,Moneesh Chatterjee,Steve Kubala et al. Chad W Johnson et al.
The introduction of lean thinking and Six Sigma methodologies into the drug discovery process has become an important approach for ensuring efficient workflows while containing costs. For the compound management department at Bristol-Myers ...
Sandra L Matson,Moneesh Chatterjee,David A Stock et al. Sandra L Matson et al.
Preserving the integrity of the compound collection and providing high-quality materials for drug discovery in an efficient and cost-effective manner are 2 major challenges faced by compound management (CM) at Bristol-Myers Squibb (BMS). Th...
Emrin Zitha-Bovens,Peter Maas,Dick Wife et al. Emrin Zitha-Bovens et al.
The technological evolution of the 1990s in both combinatorial chemistry and high-throughput screening created the demand for rapid access to the compound deck to support the screening process. The common strategy within the pharmaceutical ...
M Allen,M J Wigglesworth M Allen
Historically, sample management successfully focused on providing compound quality and tracking distribution within a diverse geographic. However, if a competitive advantage is to be delivered in a changing environment of outsourcing, effic...
Mark K Haynes,J Jacob Strouse,Anna Waller et al. Mark K Haynes et al.
Prostate cancer is a leading cause of death among men due to the limited number of treatment strategies available for advanced disease. Discovery of effective chemotherapeutics involves the identification of agents that inhibit cancer cell ...
Zoe Blaxill,Sue Holland-Crimmin,Rob Lifely Zoe Blaxill
It is common knowledge in the pharmaceutical industry that the quality of a company's compound collection has a major influence on the success of biological screening in drug discovery programs. DMSO is the widely accepted solvent of choice...
Michael Habig,Anke Blechschmidt,Sigmar Dressler et al. Michael Habig et al.
High-throughput screening often identifies not only specific, stoichiometrically binding inhibitors but also undesired compounds that unspecifically interfere with the targeted activity by nonstoichiometrically binding, unfolding, and/or in...
Helen Wise,Paul William Abel,Darren Cawkill Helen Wise
Construction and supply of cell-based reagents for in vitro plate-based screens are often highlighted as a bottleneck within drug discovery. Recent years have seen the successful application of both cryopreservation and automation to increa...
Gregory J Crowther,Alberto J Napuli,Andrew P Thomas et al. Gregory J Crowther et al.
In the past decade, thermal melt/thermal shift assays have become a common tool for identifying ligands and other factors that stabilize specific proteins. Increased stability is indicated by an increase in the protein's melting temperature...
Hans Eriksson,Johan Brengdahl,Petter Sandström et al. Hans Eriksson et al.
Assay-ready compound plates (ARPs) are sealed assay plates that contain DMSO solutions of screening compounds predispensed for particular assays. Assays are started by adding assay buffer and reagents to the ARPs. This concept offers import...